id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345464-9cnbco2i	Kwiatkowski, S.	Why we should not stop giving aspirin to pregnant women during the COVID‐19 pandemic	2020-06-01		.txt	text/plain	903	56	54	To our knowledge, there is insufficient data to suggest an increased risk between prophylactic use of low-dose aspirin and progression of COVID-19 infection in pregnant women at risk of placental complications. To our knowledge, there are limited data to suggest that there is an association between prophylactic use of low-dose aspirin and increased risk of progression of SARS-CoV-2 infection. In our opinion, during the COVID-19 pandemic, it is still essential to provide first-trimester screening for placental complications and to prescribe low-dose aspirin in women who are identified as high risk for pre-eclampsia and fetal growth restriction. Based on the current knowledge of the epidemiological situation, the benefits of placental complication prevention outweigh the potential risks of adverse outcome related to the usage of low-dose aspirin in patients with SARS-CoV-2 infection. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes	./cache/cord-345464-9cnbco2i.txt	./txt/cord-345464-9cnbco2i.txt